Advances in infertility care in India

Infertility is growing at an alarming pace, especially in metros with frequently carried negative psychosocial implications. Of the 60 - 80 million couples suffering from infertility globally every year, between 15 - 20 million are in India alone. With advances in technology, the success rate of assisted reproduction has steadily increased in the past few years. Today the success rate of such procedures is around 35 to 40 percent.

Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:
1.    Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.
2.    Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Novel opportunities in non invasive antenatal diagnosis and fetal therapeutics

Fetal laboratory medicine offers a pioneer opportunity for diagnostic testing, forging the frontier of maternal–fetal medicine. Clinical trends in antenatal technologies today give us the future directions in noninvasive prenatal diagnostics for fetal health assessment.  A webinar is being conducted to showcase new advances in this field that will discuss the current scope and contributions of fetal laboratory testing.

Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:
1.    Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.
2.    Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Latest advances in diagnostic tools and techniques for treating infertility

Infertility is a common medical condition which can have devastating, painful, and life-long effects extending to personal relationships and wider family. This condition affects 20% of young couples and is increasing over the past decade.  Advancement in various reproductive technologies now offers the most effective treatments in a timely manner to people experiencing problems in conceiving.

Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:
1.    Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.
2.    Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Webinar symposium On the Frontier of Maternal–Fetal Medicine

Emerging antenatal interventions and care delivery to the fetus require diagnostic support, including laboratory technologies, appropriate methodologies, establishment of special algorithms, and interpretative guidelines for clinical decision-making. To hear more on these topics you are cordially invited to participate in the free webinar by registering online.
 
Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:

1. Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.

2. Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Problem with TB drugs and vaccine

Emergence of drug resistance TB in the recent years has posed a great problem with handling the disease. Irregular and misuse of TB drug isoniazid has been one of the major causes for it. Co-infection of TB with HIV makes handling the disease even more complex for administration of anti tuberculosis drugs.  Also, the major vaccine against the disease, Baccillus Calmette-Guerin (BCG) has its own side effects and in some cases has been inefficient in preventing the disease.

Webinar symposium

Need of the hour surely is to find a better way to handle it by reducing the flaws in diagnosis, treatment and better prevention of TB. 24th March is observed as the World TB day, and Dr. Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on Breakthrough in Diagnosis and Effective Treatment of TB. The webinar will be webcast on Sunday, 30th of March 2014 between 11 AM to 1 PM from Hotel Claridges, New Delhi. You are cordially invited to participate in the free webinar by registering online. A Q & A session will follow the Doctors presentation.

You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com

About the Speakers:

1.      Dr. Shalabh Malik, Head of the Microbiology Department, Dr. LalPath labs

2.      Dr. Animesh Arya, MBBS, DTCD, MD. Senior chest consultant and sleep specialist at Action Balaji medical institute and Max healthcare, Medical director at centre for chest diseases, allergy and sleep disorders.

Dr. Lal PathLabs introduces a breakthrough webinar on diagnosis and effective treatment of TB, click to know more -  http://www.drlalpathlabswebinar.com "

A Distant Dream- TB Free India

India is among these high TB burden countries with a whopping 26% of the world TB patients. With the emergence of newer strains of Mycobacterium Tuberculosis, some of which are extensively drug resistant, TB has become a challenge to treat, requiring an immediate and strong action against the disease for the wellbeing of humanity.  India, in 1948, introduced bacille Calmette-Guerin (BCG) vaccine in its mass immunization program. This program has however failed to reach its expected potential. With the introduction of Directly Observed Treatment, Short Course (DOTS) in India in 1997, a major step towards TB elimination has been taken by the government on a large scale.

Webinar symposium

Dr. Lal Path Labs, the leading and the most reputed diagnostic chain, presents a webinar symposium on Breakthrough in Diagnosis and Effective Treatment of TB. The webinar will be webcast on Sunday, 30th of March 2014 between 11 AM to 1 PM from Hotel Claridges, New Delhi. You are cordially invited to participate in the free webinar by registering online. A Q & A session will follow the Doctors presentation.

You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com

About the Speakers:

1.      Dr. Shalabh Malik, Head of the Microbiology Department, Dr. Lal Pathlabs

2.    Dr. Animesh Arya, MBBS, DTCD, MD. Senior chest consultant and sleep specialist at Action Balaji medical institute and Max healthcare, Medical director at centre for chest diseases, allergy and sleep disorders. 

"Dr. Lal PathLabs introduces a breakthrough webinar on diagnosis and effective treatment of TB, click to know more -  http://www.drlalpathlabswebinar.com "